Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Stock Options (Tables)

v3.19.3

Stock Options (Tables)

12 Months Ended

Aug. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of exercise price

Quantity		Exercise Price $		Life (Years)
	390,000⁽¹⁾		1.27	5
	240,000⁽¹⁾		1.06	5
	30,000⁽¹⁾		1.16	5
	350,000		0.99	5
	440,000⁽¹⁾		0.99	5
	48,000⁽¹⁾		0.96	5
	100,000		0.81	5
	450,000⁽¹⁾		0.81	5
	2,048,000		1.00
⁽¹⁾Options granted vest over a period of three years

Schedule for stock options

Options

Weighted

Average

Exercise

Price $

Weighted

Average Remaining Contractual

Term (Years)

Aggregate

Intrinsic

Value $

Balance August 31, 2017

3,320,875

0.15

Exercised

(545,875

)

0.17

Granted

2,025,000

1.49

Balance August 31, 2018

4,800,000

0.71

Expired/Cancelled

(1,415,000

)

0.66

Exercised

(430,000

)

0.15

Granted

2,048,000

1.00

Balance August 31, 2019 (Outstanding)

5,003,000

0.89

3.34

791,800

Balance August 31, 2019 (Exercisable)

3,961,000

0.90

3.03

752,300

Schedule of fair value of options granted using Black-Scholes option pricing model

	August 31 2019	August 31 2018
Expected volatility	100% – 144%	127% – 131%
Risk-free interest rate	1.42% – 2.89%	2.13% – 2.74%
Expected life	5 years	5 years
Dividend yield	0.00%	0.00%
Estimated fair value per option	$0.60 - $1.07	$0.70 – $1.73

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration